cabotegravir Report issue

Small molecule Approved FDA Fast Track FDA Priority Review FDA

Active Ingredient History

NOW
  • Now
Cabotegravir, sold under the brand name Vocabria among others, is a antiretroviral medication used for the treatment of HIV/AIDS. It is available in the form of tablets and as an intramuscular injection, as well as in an injectable combination with rilpivirine under the brand name Cabenuva.   Wikipedia

  • SMILES: C[C@H]1CO[C@@H]2CN3C=C(C(=O)NCc4ccc(F)cc4F)C(=O)C(=C3C(=O)N12)O
  • InChIKey: WCWSTNLSLKSJPK-LKFCYVNXSA-N
  • Mol. Mass: 405.36
  • ALogP: 0.96
  • ChEMBL Molecules:
More Chemistry

Combination drugs

( cabotegravir, rilpivirine (edurant) - other name: cabotegravir and rilpivirine -extended release injectable suspension )
cabotegravir | cabotegravir sodium | gsk1265744 | gsk1265744a | gsk1265744b | gsk744 | n-((2,4-difluorophenyl)methyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro(1,3)oxazolo(3,2-a)pyrido(1,2-d)pyrazine-8-carboxamide | s-265744b

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue